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Abstract 
A new, versatile and highly stereoselective approach for the synthesis of non-racemic 3-
substituted isoindolin-1-ones is described from a readily available chiral template. The 
potential of this new protocol is demonstrated through the synthesis of an enantiomerically 
enriched 3-alkyl N-H isoindolin-1-one target with an e.e. of 98%.  
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1. Introduction 
The synthesis of non-racemic 3-substituted isoindolin-1-one targets remains an area of 
significant interest due to the wide range of biological activities exhibited by this class of 
compound. Typical examples of bioactive targets include compounds 1-3 (Figure 1). (S)-PD-
172938, 1, shows affinity for dopamine D4 receptors,1 whilst (S)-pagoclone, 2, is known to 
display anxiolytic activity2 and JM-1232, 3, is a benzodiazepine receptor agonist also being 
investigated for the treatment of anxiety related conditions.3 Selected biological activities of 
other, related, 3-substituted isoindolin-1-one derivatives include affinity for 5-HT receptors,4 
as inhibitors of the MDM2-p53 protein-protein interaction,5 and as Kv1.5 ion channel 
blockers.6 
 
 
Figure 1. Biologically Active 3-Substituted Isoindolin-1-ones. 
 
Deprotonation and subsequent benzylic C-alkylation of the parent isoindolinone template has 
been previously explored as a route to such targets in racemic form.7 This approach has been 
extended to include chiral auxiliary based approaches for the asymmetric synthesis of non-
racemic 3-substituted isoindolin-1-ones: for example in Couture’s application of an 
aminoprolinol-derived template,8 Royer’s use of phenylglycinol,9 and Comins’ approach using 
TCC esters for control of asymmetric alkylation.10 
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In our own previous contribution to this area we pioneered the use of readily accessible Meyers-
type tricyclic lactams, 4, as versatile asymmetric building blocks, and reported the successful 
synthesis of non-racemic 3-alkyl and 3-aryl isoindolin-1-ones.11 Appropriately substituted 
chiral templates, 4, were used as novel N-acyliminium precursors which could be activated 
towards subsequent reaction with carbon nucleophiles (Scheme 1, path 1), or with hydride 
(Scheme 1, path 2) in order to deliver the desired 3-substituted isoindolin-1-one targets.  
Although pathway 1 was found to suffer from low levels of product diastereoselectivity, we 
discovered that a complementary approach, pathway 2, delivered up to exclusive levels of 
product diastereoselectivity. We have also demonstrated two effective methods for removal of 
the phenylglycinol chiral auxiliary to deliver the corresponding enantio-enriched 3-alkyl and 
3-aryl substituted NH-isoindolinones, 5, with minimal loss of stereochemical integrity at the 
newly created chiral centre.11 
 
Scheme 1. Approaches to Non-racemic 3-Substituted Isoindolin-1-one Targets Using a 
Tricyclic Lactam Template. 
 
We were intrigued by the subsequent work from the aforementioned groups of Couture,8 
Royer9 and Comins10 which have each approached this challenge by generating an anion at the 
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benzylic position of suitably derivatized, non-racemic isoindolinone intermediates, followed 
by an asymmetric alkylation protocol - a complementary approach to our own routes.  
In this present paper we describe a novel application of the “Meyers’” tricyclic lactams in an 
analogous anionic approach to the targets of interest (Scheme 1, path 3), which significantly 
extends our earlier work in this area by overcoming a number of potentially limiting factors, 
such as the lack of availability of appropriate ketoacid building blocks, and so allows for the 
preparation of a wider range of the intermediate templates, 4. 
 
2. Results and Discussion 
In the new approach described in this paper we have utilized the (R)-phenylglycinol derived 
template, 6, readily prepared as previously described by us in 75% yield as a single 
diastereoisomer through Dean-Stark condensation of the commercially available enantiopure 
aminoalcohol with 2-carboxybenzaldeyde.11 
In our exploratory work (Scheme 2), template 6 was deprotonated using 1.1 eq. of LHMDS at 
-78 oC in dry THF and the intermediate anion was then alkylated with 1.2 eq. MeI to generate 
the alkylated template 7 as a 1:1 mixture of diastereoisomers, as determined by 400 MHz 1H-
NMR spectroscopy on the crude reaction mixture (Step 1).  
The lack of any diastereoselectivity observed in the synthesis of intermediate 7 is of no 
consequence to our ultimate goal, since the subsequent step of this new approach involves the 
generation of a planar N-acyliminium species on activation of 7, where any stereochemistry 
that was established during the initial alkylation step would be lost. followed by the second 
stage of the process, a stereoselective reduction of the non-racemic N-acyliminium 
intermediate with a silane-based hydride reagent, which would be expected to induce high 
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levels of diastereoselectivity in the final product, based on our previous experience with these 
templates.11 
Our results are presented in Table 1 for alkylation of template 6 using a representative range 
of alkyl halides. For allyl bromide, which gave the highest level of diastereoselectivity when 
using LiHMDS as the base, alternative bases were investigated due to the significance of the 
counterion on the diastereoisomeric product ratio in related studies.9  
 
 
Scheme 2. (i) 1.1 eq. Base, THF, -78 oC; (ii) 1.2 eq. Alkyl halide, THF, -78 oC to R.T. (12 h), 
then H3O+; (iii) 1.5 eq. TiCl4, DCM, -78 oC; (iv) 1.5 eq. Et3SiH, THF, -78 oC to R.T. 
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Table 1. Diastereoselective Alkylation of Tricyclic Lactam, 6. 
Base Alkyl halide Diastereoisomeric 
Ratioa 
% conversiona 
LiHMDS Me-I 50:50 50 
LiHMDS Benzyl-Br 75:25 94 
LiHMDS Allyl-Br 80:20 96 
NaHMDS Allyl-Br 90:10 50 
KHMDS Allyl-Br 86:14 57 
adetermined by 400 MHz 1H-NMR spectroscopy on the crude reaction mixture. 
 
As can be seen from Table 1, the highest level of diastereoselectivity achieved with allyl 
bromide as the electrophile was in the presence of sodium as the counterion, although this base 
(NaHMDS) gave the poorest conversion (50%) by 400 MHz 1H NMR. A significantly higher 
conversion of 96% was achieved with LiHMDS. In examples where the conversion was 
observed to be low, the 400 MHz 1H NMR spectra of the crude product mixture showed only 
the presence of non-alkylated starting material as a by-product. Variation of the number of 
equivalents of both base and alkyl halide did not improve the observed outcome. 
As noted by Couture,8 the deprotonated species 6a may undergo delocalization to form the 
alternative extended enolate 6b. It may be tempting to suggest that a preference for one enolate 
form over the other (6a : 6b) in the presence of a given base may help to rationalize the 
observed diastereoselectivities of the alkylation step, although there may be other factors at 
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play and so we would prefer not to speculate further at this juncture, particularly as the 
stereoselective outcome of this initial alkylation reaction is of no consequence to the overall 
success of this new approach to the 3-substituted isonidolino-1-one targets. 
 
We were pleased to find that reductive ring-opening of intermediate 7 using 1.5 eq. 
triethylsilane in the presence of 1.5 eq. TiCl4 in dry DCM gave the desired 3-methyl 
isoindolino-1-one, 8a, in 32% yield (over 2 steps) as a ≥95:5 mixture of diastereoisomers by 
1H NMR spectroscopy (Scheme 2, Table 2). 
 
Access to compound 8a, prepared by us in our previous research efforts,11 allowed us to 
determine that the relative stereochemistry of the major diastereoisomer was as shown in 
Scheme 2, by comparison of 1H NMR data. The observed stereochemical outcome can be 
rationalized by reference to our usual conformational model (Scheme 2). 
 
Having established that this new approach to the synthesis of 3-substituted isoindolin-1-one 
targets had significant potential, we explored the application of a range of alkylating agents 
(Table 2). Based on the model study outlined in Table 1, we chose to use LiHMDS as the base, 
since this base gave highest conversions. Although the initial diastereoselectivity for alkylation 
of the template using LiHMDS was the lowest for those bases explored, this would be of no 
consequence to the formation of the desired non-racemic 3-substituted isoindolin-1-one targets 
with high levels of diastereoselectivity. The alkylated intermediate from Step 1 was not isolated 
during this reaction sequence, but instead was subjected to the reductive ring opening in Step 
2.  
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Table 2. Template Derivatization and Diastereoselective Ring Opening. 
 
Alkyl halide Step 1 
conversion 
(%)a 
diastereoisomeric 
ratio 
(step 1)a 
product diastereoisomeric 
ratio 
 (step 2) a 
yield 
(%)b 
methyl iodide 50 50:50 8a ≥95:5 32 
ethyl iodide 81 50:50 8b ≥95:5 47 
propyl iodide 78 66:34 8c ≥95:5 32 
allyl bromide 96 80:20 8d ≥95:5 49 
benzyl bromide 94 60:40 8e ≥95:5 35 
2-fluorobenzyl 
bromide 
94 83:17 8f ≥95:5 65 
3-methoxybenzyl 
bromide 
96 80:20 8g ≥95:5 61 
a determined by 400 MHz 1H NMR spectroscopy on the crude reaction mixture. 
b overall isolated yield after 2 steps, following purification by flash column chromatography. 
 
As can be seen from Table 2, alkylation of the parent template could be achieved with variable 
levels of diastereoselectivity at the intermediate stage of the synthetic sequence (Step 1). In all 
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cases, the reductive ring-opening of the intermediate proceeded to deliver excellent levels of 
product diastereoselectivity (Step 2) for all final target compounds. Although the overall yields 
of the desired products are only low to moderate, the yields quoted for products 8a-g in Table 
2 are over the two reaction steps from template 6, following purification by column 
chromatography. In all cases, the major by-product of the two-step procedure was formation 
of the corresponding ring-opened product from the presence of unalkylated template 6 
following Step 1, which was readily separable from the desired products by column 
chromatography. 
 
 
Figure 2. Single Crystal X-Ray Structure of Compound 8e. 
 
X-Ray crystal structures were obtained for the major diastereoisomers of products 8b, 8d and 
8e; with that of benzyl-substituted product 8e shown in Figure 2. Interestingly, the relative 
stereochemistry of the allyl-substituted product 8d is, as expected from our rationale,  opposite 
to that observed when accessing the same compound via our alternative, complementary 
approach using a carbon-centred nucleophile (allyl trimethylsilane, Scheme 1, path 1), thus 
further supporting the conformational model that we have proposed to rationalize the 
stereochemical induction that is observed on ring opening of such tricyclic lactam substrates 
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(Scheme 2). The induced relative stereochemistry in the reaction sequence is governed by the 
approach of the corresponding nucleophile: hydride in this current study, but allyl in our 
previous work, thus leading to the observed opposite relative stereochemistry.11  
One major advantage of our new approach, described herein, is the significant increase in 
product diastereoselectivity that can be achieved for a wider range of 3-position substituents: 
for example, allyl derivative 8d was isolated as a ≥95:5 ratio of diastereoisomers using our new 
approach, whereas our previously reported methodology delivered this target compound with 
a diastereoisomeric ratio of only 2:1.11 
In order to demonstrate the synthetic potential of this new methodology as a potential route to 
access enantiomerically enriched 3-substituted NH-isoindolin-1-one targets, we then subjected 
major diastereoisomer 8a to our previously developed method for cleavage of the chiral 
auxiliary group (Scheme 3).11 Thus, treatment of 8a with 96% sulfuric acid over a reaction 
time of just 2 minutes at 95 oC gave a 38% yield of (R)-3-methyl isoindolino-1-one, 9, with 
98% e.e. (as determined by chiral HPLC).12 
 
 
Scheme 3. Access to Enantiomerically Enriched 3-Substituted Isoindolin-1-one Target, 9. 
 
3. Conclusion 
Our previously reported approach to the synthesis of non-racemic 3-substituted isoindolin-1-
ones relied upon the availability of appropriate keto-acid substrates, which could be a limiting 
factor in the introduction of structural diversity to the chiral templates. Given the ready 
N
O
Ph
Me OHH
9
NH
O
Me H
8a
96% H2SO4
95 oC, 2 min.
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availability of a wide range of alkylating agents, our new approach described herein now 
circumvents this issue, since it allows for the synthesis of an extended range of 3-substituted 
isoindolin-1-one targets from a common, readily available lactam template (4, R = H), itself 
accessed as a crystalline intermediate in high yield in one step from commercially available 
substrates. Further applications of this methodology in target synthesis are underway, and will 
be reported in due course. 
 
4. Experimental 
Materials and Methods 
1H and 13C nuclear magnetic resonance (NMR) were measured on a Jeol eclipse 400 MHz 
spectrometer using CDCl3, at 400 MHz for 1H NMR and 100 MHz for 13C NMR. Chemical 
shifts are quoted in ppm downfield from TMS; coupling constants (J) are quoted in Hertz (Hz). 
TMS was defined as 0 ppm in 1H NMR and the residual chloroform triplet as 77.10 ppm in 13C 
NMR. The following abbreviations were used in analysis; broad (br), singlet (s), doublet (d), 
triplet (t), quartet (q), double doublet (dd), doublet of doublet of doublets (ddd), doublet of 
triplets (dt)  and multiplet (m). Mass spectra were obtained from the EPSRC National Mass 
Spectrometry Centre at Swansea University using electron spray ionisation (ES). Infra-red 
spectra were recorded in the range 4000-600 cm-1 using a Perkin Elmer spectrum 100 FT-IR 
spectrometer. Optical rotation measurements were obtained from a Bellingham and Stanley 
ADP440+ Polarimeter, at 24 oC, at a concentration of 0.5 g/100 ml-1, with a cell length of 5cm. 
Melting points were measured on a Stuart SMP10 melting point apparatus. 
Reagents and solvents were purchased from Sigma-Aldrich, Acros Organics and Alfa Aesar, 
and were used without further purification. Anhydrous solvents (used where specified) were 
purchased from Sigma-Aldrich and used without further drying. Reactions were carried out 
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under a flow of nitrogen gas, where specified. Dry ice/acetone baths were used to cool reactions 
to -78 ̊C. 
The progress of the reactions was monitored by thin layer chromatography (TLC), using glass 
pre-coated silica gel plates (Merck) visualized by UV irradiation at a wavelength of 254 nm. 
Flash column chromatography was carried out on silica gel 60 (43-60 mesh) (Fluorochem). 
 
 (3R,9bS)-3-phenyl-2,3-dihydrooxazolo[2,3-a]isoindol-5(9bH)-one, (6).11c 
(R)-Phenylglycinol, (5.00g, 36 mmol, 1 eq.) was heated with 2-carboxybenzaldehyde (6.02g, 
40 mmol, 1.1 eq.) in toluene (300 mL) under Dean-Stark conditions for 48 hours. The crude 
reaction mixture was then evaporated to yield an oil, which was purified by flash column 
chromatography (50:50 Et2O/petroleum ether (40-60)). Evaporation of the solvents under 
reduced pressure afforded a white crystalline solid. Yield: 75% (5.50 g); Mp: 117-119 ̊C 
(DCM/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.97 - 7.78 (m, 1H), 7.71 - 7.55 (m, 3H), 7.51 
- 7.29 (m, 5H), 6.06 (s, 1H), 5.23 (t, J = 7.4 , 1H), 4.85 (dd, J = 7.4, 8.8, 1H), 4.17 (dd, J = 7.4, 
8.8, 1H). 
 
(R)-2-((R)-2-hydroxy-1-phenylethyl)-3-methylisoindolin-1-one, 8a. 
Compound 6, (1.00g, 3.96 mmol, 1.0 eq.) was dissolved in dry THF (15 mL, dry) under 
nitrogen and the solution cooled to -78 ̊C. LiHMDS (1M in THF) (4.36 mL, 4.36 mmol, 1.1 
eq.) was then added drop-wise and the resulting mixture stirred for 30 minutes. Methyl iodide 
(0.30 mL, 4.77 mmol, 1.2 eq.) was then added drop-wise and the solution was allowed to warm 
to room temperature overnight. Saturated NH4Cl aq. (20mL) was then added to quench the 
reaction, and the reaction mixture was then further diluted with H2O (20 mL). The mixture was 
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then extracted with 5 x 30 mL portions of Et2O and the combined organic extracts were washed 
with 1 x 30 mL brine, dried over anhydrous MgSO4, filtered and evaporated under reduced 
pressure to yield the crude product as a light brown oil which was used in the next step without 
any further purification. Analysis of the crude reaction mixture by 1H NMR spectroscopy (400 
MHz) confirmed a conversion of 50% of starting material in this synthetic step. 
The crude product (1.06 g, 3.96 mmol, 1.0 eq.) was stirred in dry DCM (15 mL), under nitrogen 
and cooled to -78 ̊C. TiCl4 (1M in DCM) (5.94 mL, 5.94 mmol, 1.5 eq.) was added drop-wise 
to the solution and left to stir for 30 minutes at -78 ̊C. Triethylsilane (0.95 mL, 5.94 mmol, 1.5 
eq.) was added drop-wise to the mixture, which was then allowed to warm to room temperature 
overnight. The reaction was quenched by the addition of saturated NH4Cl aq. (20 mL) and then 
diluted further with H2O (20 mL). The mixture was extracted with 3 x 40 mL portions of DCM 
and the organic extracts combined and washed with 30 mL brine, dried over anhydrous MgSO4, 
filtered and evaporated under reduced pressure to give a light brown residue. This was then 
purified by flash column chromatography (100% petroleum ether (40-60)) to afford a yellow 
oil. Yield: 32% (0.34 g); [α]D = + 244 (c 0.5, 24 oC, DCM); 1H NMR (400 MHz, CDCl3) δ 7.88 
(d, J = 7.4, 1H), 7.62 - 7.44 (m, 2H), 7.39 - 7.26 (m, 6H), 5.00 - 4.89 (m, 1H), 4.77 (dd, J = 
3.4, 8.0, 1H), 4.53 - 4.43 (m, 1H), 4.34 (q, J = 6.7, 1H), 4.18 - 4.05 (m, 1H), 1.46 (d, J = 6.7, 
3H); 13C NMR (100 MHz, CDCl3) δ 169.7, 147.1, 137.9, 132.1, 128.9, 128.4, 128.1, 127.3, 
123.9, 122.0, 64.7, 62.5, 57.1, 18.4; νmax (solid): 3333, 1658, 1469, 1404, 1353 cm-1; HRMS 
(ESI, m/z): calcd. for C17H17NO2 (M + H+) 268.1332, found: 268.1334. 
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 (R)-3-ethyl-2-((R)-2-hydroxy-1-phenylethyl)isoindolin-1-one, (8b). 
Compound 6, (0.50g, 1.98 mmol, 1.0 eq.) was dissolved in dry THF (15 mL) under nitrogen 
and the solution cooled to -78 ̊C. LiHMDS (1M in THF) (2.18 mL, 2.18 mmol, 1.1 eq.) was 
added drop-wise and the resulting mixture stirred for 30 minutes. Ethyl iodide (0.19 mL, 2.39 
mmol, 1.2 eq.) was then added drop-wise and the solution was allowed to warm to room 
temperature overnight. Saturated NH4Cl aq. (15 mL) was then added to quench the reaction, 
which was then diluted further with H2O (20 mL). The mixture was then extracted with 5 x 30 
mL portions of Et2O and the organic extracts were combined and washed with 1 x 30 mL brine, 
dried over anhydrous MgSO4, filtered and evaporated to give the crude intermediate as an 
orange oil, which was used in the next step without any further purification. Analysis of the 
crude reaction mixture by 1H NMR spectroscopy (400 MHz) confirmed a conversion of 81% 
of starting material in this synthetic step. 
The crude product (0.55 g, 1.98 mmol, 1.0 eq.) was stirred in dry DCM (10 mL), under nitrogen 
and cooled to -78 ̊C. TiCl4 (1M in DCM) (2.97 mL, 2.97 mmol, 1.5 eq.) was added drop-wise 
and the solution left to stir for 30 minutes at -78 C̊. Triethylsilane (0.47 mL, 2.97 mmol, 1.5 
eq.) was added drop-wise to the mixture, which was then allowed to warm to room temperature 
overnight. The reaction was quenched by addition of saturated NH4Cl aq. (20 mL) and the 
mixture further diluted with H2O (20 mL). The mixture was then extracted with 3 x 30 mL 
portions of DCM and the combined organic extracts washed with 1 x 30 mL brine, dried over 
anhydrous MgSO4, filtered and evaporated under reduced pressure to give a light brown residue 
which was purified by flash column chromatography (80:20 EtOAc/ petroleum ether (40-60)) 
to afford the target compound as a yellow crystalline solid. Yield: 47% (0.26 g); Mp: 101-104 
⁰C (DCM/hexanes); [α]D = + 180 (c 0.5, 24 oC, DCM); νmax (solid): 3345, 2995, 2876, 1659, 
1469, 1407, 1214 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 7.5, 1H), 7.62 - 7.40 (m, 
2H), 7.38 - 7.26 (m, 6H), 7.38 - 7.21 (m, 1H), 5.07 - 4.99 (m, 1H), 4.62 (dd, J = 3.3, 8.0, 1H), 
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4.48 (dt, J = 7.9, 12.5, 1H), 4.40 (dd, J = 2.7, 5.1, 1H), 4.11 (ddd, J = 3.3, 7.0, 12.5, 1H), 2.13 
- 1.90 (m, 2H), 0.55 (t, J = 7.4, 3H); 13C NMR (100 MHz, CDCl3) δ 170.4, 144.9, 138.0, 132.9, 
132.0, 128.9, 128.4, 128.1, 127.3, 123.8, 122.0, 64.8, 62.8, 61.1, 22.9, 5.9; HRMS (ESI, m/z): 
calcd. for C18H19NO2 (M + H+) 282.1489, found 282.1489.  
 
 (R)-2-((R)-2-hydroxy-1-phenylethyl)-3-propylisoindolin-1-one, (8c). 
Compound 6, (0.50 g, 1.98 mmol, 1.0 eq.) was dissolved in dry THF, (15 mL), under nitrogen 
and the solution cooled to -78 ̊C. LiHMDS (1M in THF) (2.18 mL, 2.18 mmol, 1.1 eq.) was 
then added drop-wise and the resulting mixture stirred for 30 minutes. 1-Iodopropane (0.23 
mL, 2.39 mmol, 1.2 eq.) was then added drop-wise and the solution was allowed to warm to 
room temperature overnight. Saturated NH4Cl aq. (15 mL) was then added to quench the 
reaction, which was then diluted further with H2O (20 mL). The mixture was then extracted 
with 5 x 30 mL portions of Et2O and the organic extracts were combined and washed with 1 x 
30 mL brine, dried over anhydrous MgSO4, filtered and evaporated under reduced pressure to 
give the crude intermediate as a light brown oil, which was used in the next step without any 
further purification. Analysis of the crude reaction mixture by 1H NMR spectroscopy (400 
MHz) confirmed a conversion of 78% of starting material in this synthetic step. 
The crude product (0.58 g, 1.98 mmol, 1.0 eq.) was stirred in dry DCM (10 mL), under nitrogen 
and cooled to -78 ̊C. TiCl4 (1M in DCM) (2.97 mL, 2.97 mmol, 1.5 eq.) was added drop-wise 
and the solution left to stir for 30 minutes at -78 C̊. Triethylsilane (0.47 mL, 2.97 mmol, 1.5 
eq.) was added drop-wise to the mixture, which was then allowed to warm to room temperature 
overnight. The reaction was quenched by addition of saturated NH4Cl aq. (20mL) and the 
mixture further diluted with H2O (20 mL). The mixture was then extracted with 3 x 30 mL 
portions of DCM and the combined organic extracts washed with 1 x 30 mL brine, dried over 
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anhydrous MgSO4, filtered and evaporated under reduced pressure to give a light brown residue 
which was purified by flash column chromatography (80:20 EtOAc/ petroleum ether (40-60)) 
to afford the target compound as white crystalline solid. Yield: 32% (0.19 g); Mp: 149-151 ⁰C 
(DCM/hexanes); [α]D = + 132 [c 0.5, 24 oC, DCM]; νmax (solid): 3300, 2998, 2875, 1660, 1413, 
1305, 1216 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.87 (d, J = 7.5, 1H), 7.61 - 7.42 (m, 2H), 7.38 
- 7.15 (m, 6H), 5.08 - 4.94 (m, 1H), 4.66 (dd, J = 3.4, 8.0, 1H), 4.47 (dt, J = 7.9, 12.5, 1H), 
4.42 - 4.31 (m, 1H), 4.09 (ddd, J = 3.4, 7.3, 12.4, 1H), 2.02 - 1.79 (m, 2H), 1.29 - 1.09 (m, 1H), 
0.88 - 0.68 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 170.2, 145.4, 137.9, 132.5, 131.8, 128.8, 
128.2, 127.9, 127.1, 123.7, 121.9, 64.7, 62.6, 60.5, 32.3, 15.1, 13.9; HRMS (ESI, m/z): calcd. 
for C19H21NO2 (M + H+) 296.1645, found 296.1644.  
 
(R)-3-allyl-2-((R)-2-hydroxy-1-phenylethyl)isoindolin-1-one, (8d). 
Compound 6, (1.00 g, 3.96 mmol, 1.0 eq.) was dissolved in dry THF, (15 mL), under nitrogen 
and the solution cooled to -78 ̊C. LiHMDS (1M in THF) (4.36 mL, 4.36 mmol, 1.1 eq.) was 
then added drop-wise and the resulting mixture stirred for 30 minutes. Allyl bromide (0.41 mL, 
4.77 mmol, 1.2 eq.) was then added drop-wise and the solution was allowed to warm to room 
temperature overnight. Saturated NH4Cl aq. (15mL) was then added to quench the reaction, 
which was then diluted further with H2O (20 mL). The mixture was then extracted with 5 x 30 
mL portions of Et2O and the organic extracts were combined and washed with 1 x 30 mL brine, 
dried over anhydrous MgSO4, filtered and evaporated under reduced pressure to give the crude 
intermediate as an orange oil, which was used in the next step without any further purification. 
Analysis of the crude reaction mixture by 1H NMR spectroscopy (400 MHz) confirmed a 
conversion of 96% of starting material in this synthetic step. 
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The crude product (1.15 g, 3.96 mmol, 1.0 eq.) was stirred in dry DCM (10 mL), under nitrogen 
and cooled to -78 ̊C. TiCl4 (1M in DCM) (5.94 mL, 5.94 mmol, 1.5 eq.) was added drop-wise 
and the solution left to stir for 30 minutes at -78 C̊. Triethylsilane (0.95 mL, 5.94 mmol, 1.5 
eq.) was added drop-wise to the mixture, which was then allowed to warm to room temperature 
overnight. The reaction was quenched by addition of saturated NH4Cl aq. (20mL) and the 
mixture further diluted with H2O (20 mL). The mixture was then extracted with 3 x 30 mL 
portions of DCM and the combined organic extracts washed with 1 x 30 mL brine, dried over 
anhydrous MgSO4, filtered and evaporated under reduced pressure to give a light brown residue 
which was purified by flash column chromatography (80:20 EtOAc/ petroleum ether (40-60)) 
to afford the target compound as a yellow solid. Yield: 49% (0.57 g); Mp: 109-112 ⁰C 
(DCM/hexanes); [α]D = + 104 (c 0.5, 24 oC, DCM); νmax (solid): 3381, 2924, 1725, 1646, 1406 
cm-1; 1H NMR (400 MHz, CDCl3) δ 7.87 (d, J = 7.4, 1H), 7.60 - 7.44 (m, 2H), 7.41 - 7.21 (m, 
6H), 5.56 - 5.15 (m, 1H), 5.12 - 4.96 (m, 3H), 4.74 (dd, J = 3.2, 7.7, 1H), 4.49 - 4.36 (m, 2H), 
4.13 (m, 1H), 2.80 - 2.48 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 170.1, 144.8, 137.8, 132.3, 
131.8, 130.4, 128.8, 128.3, 127.9, 127.1, 123.7, 122.2, 119.7, 64.5, 62.6, 59.9, 34.9; HRMS 
(ESI, m/z): calcd. for C19H19NO2 (M + H+) 294.1489, found 294.1490.  
 
(R)-3-benzyl-2-((R)-2-hydroxy-1-phenylethyl)isoindolin-1-one, (8e). 
Compound 6, (0.50 g, 1.98 mmol, 1.0 eq.) was dissolved in dry THF, (15 mL), under nitrogen 
and the solution cooled to -78 ̊C. LiHMDS (1M in THF) (2.18 mL, 2.18 mmol, 1.1 eq.) was 
then added drop-wise and the resulting mixture stirred for 30 minutes. Benzyl bromide (0.31 
mL, 2.39 mmol, 1.2 eq.) was then added drop-wise and the solution was allowed to warm to 
room temperature overnight. Saturated NH4Cl aq. (15mL) was then added to quench the 
reaction, which was then diluted further with H2O (20 mL). The mixture was then extracted 
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with 5 x 30 mL portions of Et2O and the organic extracts were combined and washed with 1 x 
30 mL brine, dried over anhydrous MgSO4, filtered and evaporated under reduced pressure to 
give the crude intermediate as a light orange solid, which was used in the next step without any 
further purification. Analysis of the crude reaction mixture by 1H NMR spectroscopy (400 
MHz) confirmed a conversion of 94% of starting material in this synthetic step. 
The crude product (0.68 g, 1.98 mmol, 1.0 eq.) was stirred in dry DCM (10 mL), under nitrogen 
and cooled to -78 ̊C. TiCl4 (1M in DCM) (2.97 mL, 2.97 mmol, 1.5 eq.) was added drop-wise 
and the solution left to stir for 30 minutes at -78 C̊. Triethylsilane (0.47 mL, 2.97 mmol, 1.5 
eq.) was added drop-wise to the mixture, which was then allowed to warm to room temperature 
overnight. The reaction was quenched by addition of saturated NH4Cl aq. (20mL) and the 
mixture further diluted with H2O (20 mL). The mixture was then extracted with 3 x 30 mL 
portions of DCM and the combined organic extracts washed with 1 x 30 mL brine, dried over 
anhydrous MgSO4, filtered and evaporated under reduced pressure to give a light brown residue 
which was purified by flash column chromatography (80:20 EtOAc/ petroleum ether (40-60)) 
to afford the target compound as a white crystalline solid. Yield: 35% (0.24 g); Mp: 174-177 
̊C (EtOAc/hexanes); [α]D = + 124 (c 0.5, 24 oC, DCM); νmax (solid): 3380, 2924, 2885, 1649, 
1408 cm-1;  1H NMR (400 MHz, CDCl3) δ 7.84 - 7.74 (m, 1H), 7.51 - 7.14 (m, 10H), 6.98 - 
6.91 (m, 2H), 6.88 - 6.78 (m, 1H), 5.10 - 4.95 (m, 1H), 4.87 (dd, J = 3.4, 7.8, 1H), 4.54 (dd, J 
= 4.5, 7.8, 1H), 4.46 (dt, J = 7.7, 12.5, 1H 1H), 4.09 (ddd, J = 3.3, 6.9, 12.4, 1H), 3.37 (dd, J = 
4.4, 13.9, 1H), 2.88 (dd, J = 7.8, 13.8, 1H); 13C NMR (100 MHz, CDCl3) δ 169.9, 144.9, 137.9, 
135.4, 132.0, 131.4, 129.4, 128.9, 128.4, 128.3, 128.0, 127.1, 127.1, 123.7, 122.8, 64.6, 63.1, 
61.7, 38.1; HRMS (ESI, m/z): calcd. for C23H21NO2 (M + H+) 344.1645, found 344.1643.  
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(R)-3-(2-fluorobenzyl)-2-((R)-2-hydroxy-1-phenylethyl)isoindolin-1-one, (8f). 
Compound 6, (0.50 g, 1.98 mmol, 1.0 eq.) was dissolved in dry THF, (15 mL), under nitrogen 
and the solution cooled to -78 ̊C. LiHMDS (1M in THF) (2.18 mL, 2.18 mmol, 1.1 eq.) was 
then added drop-wise and the resulting mixture stirred for 30 minutes. 2-Fluorobenzyl bromide 
(0.29 mL, 2.39 mmol, 1.2 eq.) was then added drop-wise and the solution was allowed to warm 
to room temperature overnight. Saturated NH4Cl aq. (15mL) was then added to quench the 
reaction, which was then diluted further with H2O (20 mL). The mixture was then extracted 
with 5 x 30 mL portions of Et2O and the organic extracts were combined and washed with 1 x 
30 mL brine, dried over anhydrous MgSO4, filtered and evaporated under reduced pressure to 
give the crude intermediate as a light orange oil, which was used in the next step without any 
further purification. Analysis of the crude reaction mixture by 1H NMR spectroscopy (400 
MHz) confirmed a conversion of 94% of starting material in this synthetic step. 
The crude product (0.71 g, 1.98 mmol, 1.0 eq.) was stirred in dry DCM (10 mL), under nitrogen 
and cooled to -78 ̊C. TiCl4 (1M in DCM) (2.97 mL, 2.97 mmol, 1.5 eq.) was added drop-wise 
and the solution left to stir for 30 minutes at -78 C̊. Triethylsilane (0.47 mL, 2.97 mmol, 1.5 
eq.) was added drop-wise to the mixture, which was then allowed to warm to room temperature 
overnight. The reaction was quenched by addition of saturated NH4Cl aq. (20 mL) and the 
mixture further diluted with H2O (20 mL). The mixture was then extracted with 3 x 30 mL 
portions of DCM and the combined organic extracts washed with 1 x 30 mL brine, dried over 
anhydrous MgSO4, filtered and evaporated under reduced pressure to give a light brown residue 
which was purified by flash column chromatography (70:30 EtOAc/ petroleum ether (40-60)) 
to afford the target compound as an off-white crystalline solid. Yield: 65% (0.465 g); Mp: 140-
143 ̊C (EtOAc/hexanes); [α]D = + 152 (c 0.5, 24 oC, DCM); νmax (solid): 3313, 2871, 1657, 
1491, 1230 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.85 - 7.77 (m, 1H), 7.50 - 6.88 (m, 12H), 4.96 
- 4.82 (m, 2H), 4.59 (dd, J = 4.3, 7.7, 1H), 4.48 (dt, J = 7.8, 12.5, 1H), 4.13 (ddd, J = 3.4, 7.0, 
 20 
12.5, 1H), 3.43 (dd, J = 4.2, 14.0, 1H), 2.93 (dd, J = 7.7, 14.0, 1H); 13C NMR (100 MHz, 
CDCl3) δ 170.0, 161.2 (d, 1JC-F = 245.4 Hz), 144.9, 137.9, 132.1, 131.7 (d, 3JC-F = 4.8 Hz), 
131.5, 129.1 (d, 2JC-F = 7.7 Hz), 128.9, 128.4, 128.0, 127.2, 124.0 (d, 3JC-F = 3.8 Hz), 123.8, 
122.8, 122.7 (d, 4JC-F = 15.3 Hz), 115.4 (d, 2JC-F = 22.0 Hz), 64.6, 63.0, 60.5, 31.6; HRMS (ESI, 
m/z): calcd. for C23H20FNO2 (M + H+) 362.1551 found, 362.1550.  
 
(R)-2-((R)-2-hydroxy-1-phenylethyl)-3-(3-methoxybenzyl)isoindolin-1-one, (8g). 
Compound 6, (0.50 g, 1.98 mmol, 1.0 eq.) was dissolved in dry THF, (15 mL), under nitrogen 
and the solution cooled to -78 ̊C. LiHMDS (1M in THF) (2.18 mL, 2.18 mmol, 1.1 eq.) was 
then added drop-wise and the resulting mixture stirred for 30 minutes. 3-Methoxybenzyl 
bromide (0.33 mL, 2.39 mmol, 1.2 eq.) was then added drop-wise and the solution was allowed 
to warm to room temperature overnight. Saturated NH4Cl aq. (15mL) was then added to quench 
the reaction, which was then diluted further with H2O (20 mL). The mixture was then extracted 
with 5 x 30 mL portions of Et2O and the organic extracts were combined and washed with 1 x 
30 mL brine, dried over anhydrous MgSO4, filtered and evaporated under reduced pressure to 
give the crude intermediate as a light orange oil, which was used in the next step without any 
further purification. Analysis of the crude reaction mixture by 1H NMR spectroscopy (400 
MHz) confirmed a conversion of 96% of starting material in this synthetic step. 
The crude product (0.74 g, 1.98 mmol, 1.0 eq.) was stirred in dry DCM (10 mL), under nitrogen 
and cooled to -78 ̊C. TiCl4 (1M in DCM) (2.97 mL, 2.97 mmol, 1.5 eq.) was added drop-wise 
and the solution left to stir for 30 minutes at -78 C̊. Triethylsilane (0.47 mL, 2.97 mmol, 1.5 
eq.) was added drop-wise to the mixture, which was then allowed to warm to room temperature 
overnight. The reaction was quenched by addition of saturated NH4Cl aq. (20 mL) and the 
mixture further diluted with H2O (20 mL). The mixture was then extracted with 3 x 30 mL 
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portions of DCM and the combined organic extracts washed with 1 x 30 mL brine, dried over 
anhydrous MgSO4, filtered and evaporated under reduced pressure to give a light brown residue 
which was purified by flash column chromatography (70:30 EtOAc/ petroleum ether (40-60)) 
to afford the target compound as an off-white crystalline solid. Yield: 61% (0.45 g); Mp: 94-
96 ̊C (EtOAc/hexanes); [α]D = + 40 (c 0.5, 24 oC, DCM); νmax (solid): 2868, 1715, 1616, 1361, 
1311 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.84 - 7.76 (m, 1H), 7.49 - 7.40 (m, 2H), 7.38 - 7.28 
(m, 3H), 7.27 - 7.20 (m, 2H), 7.14 (t, J = 7.9, 1H), 6.96 - 6.88 (m, 1H), 6.76 (dd, J = 2.0, 8.2, 
1H), 6.56 (d, J = 7.5, 1H), 6.45 - 6.39 (m, 1H), 5.07 - 5.00 (m, 1H), 4.85 (dd, J = 3.1, 7.8 , 1H), 
4.54 (dd, J = 4.4, 7.7, 1H), 4.45 (dt, J = 7.7, 12.5, 1H), 4.08 (ddd, J = 3.3, 7.2, 12.4, 1H), 3.68 
(s, 3H), 3.34 (dd, J = 4.3, 13.9, 1H), 2.86 (dd, J = 7.8, 14.0, 1H); 13C NMR (100 MHz, CDCl3) 
δ 169.9, 159.5, 145.0, 137.9, 136.9, 132.1, 131.5, 129.4, 128.9, 128.3, 128.0, 127.2, 123.7, 
122.8, 121.8, 114.8, 112.7, 64.6, 63.1, 61.6, 55.1, 38.1; HRMS (ESI, m/z): calcd. for 
C24H23NO3 (M + H+) 374.1751 found, 374.1749.  
 
(R)-3-methylisoindolin-1-one, (9).11c 
 (R)-2-((R)-2-hydroxy-1-phenylethyl)-3-methylisoindolin-1-one, 8a, (0.05g, 0.20 mmol, 1.0 
eq.) was dissolved in conc. H2SO4 (96%, 2 mL) in a test tube. This was then immediately heated 
for two minutes over a steam bath, then cooled to room temperature. Cold H2O (20 mL) was 
then added and the mixture extracted using 3 x 20mL portions of DCM. The combined organic 
extracts were dried over anhydrous MgSO4, filtered and evaporated under reduced pressure to 
obtain a pale yellow oil.  The crude product was then purified using preparative layer 
chromatography eluting with 80:20 EtOAc/ petroleum ether (40-60), to obtain the product as a 
clear, colourless oil. Yield: 38% (0.011 g); 1H NMR (400 MHz, CDCl3) δ 7.89 - 7.77 (m, 1H), 
7.63 - 7.52 (m, 1H), 7.52 - 7.39 (m, 2H), 4.70 (q, J = 6.5, 1H), 1.51 (d, J = 6.7, 3H). 
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Enantiomeric excess (e.e) was determined independently by Reach Separations Ltd., (BioCity 
Nottingham, NG1 1GF). Analysis was carried out using a chiral stationary phase, Chiralpak IC 
column, 4.6mm x 250mm, 5m, (Daicel Chemical Industries, Ltd., Tokyo, Japan). The 
isocratic mobile phase comprised of 20:80 MeOH:CO2 (0.2% v/v NH3). The flow rate of the 
mobile phase was 4.0 mL min-1. A detector wavelength of 210-400nm was utilised. The column 
temperature was maintained at 40 oC and the injection volume was 1.0 µL. Under these 
conditions the enantiomeric excess of compound 9 was found to be 98 %, when compared to a 
racemic sample. 
X-Ray Crystallography. 
Suitable crystals were obtained by slow evaporation in ether/petrol (40-60 OC). Diffraction data 
(Mo-Kα) were collected on a Rigaku Oxford Diffraction Excalibur diffractometer at T = 150-
158 K using graphite-monochromated Mo-Kα radiation. The structures were solved and 
refined using the SHELXS-2016 and SHELXL-2016 programs.13  
8b, R = ethyl,  Crystal data: C18H16NO2, Mr = 281.34 g mol-1, orthorhombic, P212121, a = 
6.3679(2), b =7.1844(2), c = 32.8776(12) Å, V = 1504.14(9) Å3, T = 150 K, Z = 4, R[F2 > 
2σ(F2)] = 0.048 for 2711 reflections with I > 2σ(I), wR(F2) = 0.093 for all 3135 independent 
data, GOF = 1.045, 192 refined parameters.  
8d, R = allyl, Crystal data: C19H19NO2, Mr = 293.35 g mol-1, orthorhombic, P212121, a = 
9.4566(4), b =9.6198(3), c = 16.9868(7) Å, V = 1545.30(10) Å3, T = 158 K, Z = 4, R[F2 > 
2σ(F2)] = 0.042 for 3072 reflections with I > 2σ(I), wR(F2) = 0.090 for all 3364 independent 
data, GOF = 1.083, 208 refined parameters.  
8e, R = benzyl, Crystal data: C23H21NO2, Mr = 343.41 g mol-1, orthorhombic, P212121, a = 
8.6454(3), b =10.5715(3), c = 20.1931(6) Å, V = 1845.55(10) Å3,  T = 150 K, Z = 4, R[F2 > 
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2σ(F2)] = 0.053 for 3401 reflections with I > 2σ(I), wR(F2) = 0.097 for all 3860 independent 
data, GOF = 1.104, 239 refined parameters.  
The crystallographic data are deposited as CCDC 1583682,  1878667-1878668. These data can 
be obtained free of charge from The Cambridge Crystallographic Data Centre via via 
www.ccdc.cam.ac.uk/data_request/cif.   
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